Showing 281 - 300 results of 115,472 for search '(( a non decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.36s Refine Results
  1. 281
  2. 282

    Suppression of APN/CD13 expression by siRNA induced a marked decrease in migratory potential of ES-2 cells by Mikio Terauchi (35139)

    Published 2011
    “…</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC2000898.</p><p></p> A; Western blot analysis showed a decrease in APN/CD13 expression after siRNA transfection. …”
  3. 283
  4. 284

    Algorithm operation steps. by Junyan Wang (4738518)

    Published 2025
    “…Experimental results demonstrate that SCI-YOLO11 achieves a 3.2% improvement over baseline models in terms of MAP@0.5 metric; precision and recall rates increase by 2.6% and 3.7%, respectively. …”
  5. 285
  6. 286
  7. 287
  8. 288
  9. 289
  10. 290

    Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality by Johannes Raffler (793347)

    Published 2015
    “…In contrast, for the <i>SLC5A11</i> locus, we found increased levels of <i>myo</i>-inositol in urine whereas mGWAS in blood reported decreased levels for the same genetic variant. …”
  11. 291
  12. 292

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”
  13. 293
  14. 294
  15. 295
  16. 296

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state.</p><p>Results</p><p>The Ecuadorian non-diabetic controls appeared as overweight (BMI>25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients.…”
  17. 297
  18. 298
  19. 299
  20. 300